BDBM523021 1-(4-(4-amino-7-c yclopropyl-7H- pyrrolo[2,3- d]pyrimidin-5-yl)-2- methoxyphenyl)-3-(3- (1-(trifluoromethyl)cyclopropyl)isoxazol- 5-yl)urea::US11161852, Compound 55::US11713321, Example 55

SMILES COc1cc(ccc1NC(=O)Nc1cc(no1)C1(CC1)C(F)(F)F)-c1cn(C2CC2)c2ncnc(N)c12

InChI Key InChIKey=HUKGDOKRSQPPRS-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 523021   

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM523021(US11161852, Compound 55 | 1-(4-(4-amino-7-c yclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM523021(US11161852, Compound 55 | 1-(4-(4-amino-7-c yclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/4/2023
Entry Details
Go to US Patent